|Application ||WB, E|
|Other Accession||Q8C735, Q4R8N2, Q5RHQ8, NP_775106.2|
|Predicted||Zebrafish, Monkey, Mouse|
|Calculated MW||61946 Da|
|Antigen Region||132-160 aa|
|Other Names||Protein lin-9 homolog, HuLin-9, hLin-9, Beta subunit-associated regulator of apoptosis, TUDOR gene similar protein, Type I interferon receptor beta chain-associated protein, pRB-associated protein, LIN9, BARA, TGS|
|Target/Specificity||This LIN9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 132-160 amino acids from the N-terminal region of human LIN9.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||LIN9 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Acts as a tumor suppressor. Inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. Plays a role in the expression of genes required for the G1/S transition.|
|Cellular Location||Nucleus, nucleoplasm Note=Found in perinucleolar structures. Associated with chromatin|
|Tissue Location||Expressed in thymus and testis.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
LIN9 acts as a tumor suppressor. Inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. Plays a role in the expression of genes required for the G1/S transition.
Rose, J. Phd, et al. Mol. Med. (2010) In press :
Arking, D.E., et al. PLoS ONE 5 (3), E9879 (2010) :
Pilkinton, M., et al. Oncogene 26(54):7535-7543(2007)
Osterloh, L., et al. EMBO J. 26(1):144-157(2007)
Pilkinton, M., et al. J. Biol. Chem. 282(1):168-175(2007)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.